Results of a phase 1 study of quizartinib (AC220, ASP2689) in combination with induction and consolidation chemotherapy in younger patients with newly diagnosed acute myeloid leukemia Meeting Abstract
| Authors: | Altman, J. K.; Foran, J. M.; Pratz, K. W.; Trone, D.; Gammon, G.; Cortes, J. E.; Tallman, M. S. |
| Abstract Title: | Results of a phase 1 study of quizartinib (AC220, ASP2689) in combination with induction and consolidation chemotherapy in younger patients with newly diagnosed acute myeloid leukemia |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385001216 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.623.623 |
| Notes: | Meeting Abstract: 623 -- Source: Wos |
